SCHEMBL6235734

SCHEMBL6235734

CC(=S)Nc1cncs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4525457 0.79
SCHEMBL4955773 0.72
SCHEMBL3659944 0.69 CD38 (0.39)
SCHEMBL22648474 0.67 SMN1; SMN2 (0.42)
SCHEMBL2840541 0.66
SCHEMBL21999980 0.66
SCHEMBL17086160 0.66
SCHEMBL18469867 0.66
SCHEMBL1607123 0.66
SCHEMBL25475495 0.65 CSF1R (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050043381-A1 Aminopyrazole compounds AGOURON PHARMACEUTICALS, INC. 2005-02-24 US disclosed
WO-2005009435-A1 AMINOPYRAZOLE COMPOUNDS AND USE AS CHK1 INHIBITORS PFIZER INC. (US) 2005-02-03 WO disclosed